Press Releases Articles
Updates for the news media including new research findings and official AASM statements
Zepbound approval for sleep apnea: American Academy of Sleep Medicine statement
On Dec. 20, Eli Lilly announced the Food and Drug Administration has approved the injectable prescription medicine Zepbound (tirzepatide) for adults with moderate-to-severe obstructive sleep apnea and obesity. The American Academy of Sleep Medicine provides the following statement for patients and clinicians. AASM statement [...]
